Sulpiride



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Depression 36.0%
Bipolar Disorder 12.0%
Emphysema 12.0%
Product Used For Unknown Indication 12.0%
Drug Use For Unknown Indication 8.0%
Arrhythmia 4.0%
Atrial Fibrillation 4.0%
Cardiac Failure Chronic 4.0%
Cardiac Failure Congestive 4.0%
Pneumonia 4.0%
Blepharospasm 20.0%
Blood Potassium Increased 20.0%
Neuroleptic Malignant Syndrome 20.0%
Thirst 20.0%
Ventricular Extrasystoles 20.0%
Secondary
Drug Use For Unknown Indication 21.3%
Depression 16.2%
Product Used For Unknown Indication 15.3%
Schizophrenia 8.8%
Insomnia 7.5%
Depressed Mood 4.5%
Depressive Symptom 3.4%
Fatigue 3.0%
Mood Altered 2.7%
Emphysema 2.4%
Hypertension 2.1%
Atrial Fibrillation 1.9%
Ill-defined Disorder 1.7%
Psychotic Disorder 1.6%
Rheumatoid Arthritis 1.6%
Anxiety 1.5%
Abnormal Behaviour 1.2%
Major Depression 1.2%
Anxiety Disorder 1.1%
Disturbance In Attention 1.0%
Neuroleptic Malignant Syndrome 14.3%
Suicide Attempt 11.6%
Dementia 10.7%
Parkinsonism 8.9%
Tonic Convulsion 6.3%
Restlessness 5.4%
Rhabdomyolysis 5.4%
Serotonin Syndrome 5.4%
Faecaloma 3.6%
Blepharospasm 2.7%
Galactorrhoea 2.7%
Hepatic Function Abnormal 2.7%
Muscular Weakness 2.7%
Pneumonia 2.7%
Quadriplegia 2.7%
Toxic Skin Eruption 2.7%
Urinary Incontinence 2.7%
Ventricular Tachycardia 2.7%
Weight Increased 2.7%
Coma 1.8%
Concomitant
Depression 22.3%
Schizophrenia 14.4%
Drug Use For Unknown Indication 10.0%
Hypertension 8.3%
Product Used For Unknown Indication 6.6%
Rheumatoid Arthritis 6.2%
Insomnia 5.9%
Breast Cancer 3.1%
Prophylaxis 2.7%
Psychotic Disorder 2.4%
Hiv Infection 2.2%
Constipation 2.1%
Hepatitis C 2.1%
Anxiety 1.9%
Pain 1.8%
Bipolar Disorder 1.8%
Gastritis 1.7%
Headache 1.6%
Epilepsy 1.5%
Dementia 1.4%
Weight Decreased 10.4%
White Blood Cell Count Increased 8.8%
Vomiting 8.1%
Tremor 7.8%
White Blood Cell Count Decreased 7.2%
Suicidal Ideation 6.8%
Pyrexia 5.2%
Liver Disorder 4.9%
Pneumonia 4.6%
Cerebral Infarction 4.2%
Malaise 3.9%
Somnolence 3.9%
Weight Increased 3.6%
Psychotic Disorder 3.3%
Renal Failure Acute 3.3%
Rhabdomyolysis 2.9%
Urinary Tract Infection 2.9%
Urine Output Increased 2.9%
Drug Interaction 2.6%
Interstitial Lung Disease 2.6%
Interacting
Schizophrenia 50.0%
Schizophrenia, Paranoid Type 33.3%
Product Used For Unknown Indication 16.7%
Completed Suicide 40.0%
Hyperprolactinaemia 20.0%
Loss Of Consciousness 20.0%
Tremor 20.0%